Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis

World J Gastroenterol. 2016 Mar 28;22(12):3441-50. doi: 10.3748/wjg.v22.i12.3441.

Abstract

Aim: To investigate the relationship between osteopontin plasma concentrations and the severity of portal hypertension and to assess osteopontin prognostic value.

Methods: A cohort of 154 patients with confirmed liver cirrhosis (112 ethylic, 108 men, age 34-72 years) were enrolled in the study. Hepatic venous pressure gradient (HVPG) measurement and laboratory and ultrasound examinations were carried out for all patients. HVPG was measured using a standard catheterization method with the balloon wedge technique. Osteopontin was measured using the enzyme-linked immunosorbent assay (ELISA) method in plasma. Patients were followed up with a specific focus on mortality. The control group consisted of 137 healthy age- and sex- matched individuals.

Results: The mean value of HVPG was 16.18 ± 5.6 mmHg. Compared to controls, the plasma levels of osteopontin in cirrhotic patients were significantly higher (P < 0.001). The plasma levels of osteopontin were positively related to HVPG (P = 0.0022, r = 0.25) and differed among the individual Child-Pugh groups of patients. The cut-off value of 80 ng/mL osteopontin distinguished patients with significant portal hypertension (HVPG above 10 mmHg) at 75% sensitivity and 63% specificity. The mean follow-up of patients was 3.7 ± 2.6 years. The probability of cumulative survival was 39% for patients with HVPG > 10 mmHg and 65% for those with HVPG ≤ 10 mmHg (P = 0.0086, odds ratio (OR), 2.92, 95% confidence interval (CI): 1.09-7.76). Osteopontin showed a similar prognostic value to HVPG. Patients with osteopontin values above 80 ng/mL had significantly lower cumulative survival compared to those with osteopontin ≤ 80 ng/mL (37% vs 56%, P = 0.00035; OR = 2.23, 95%CI: 1.06-4.68).

Conclusion: Osteopontin is a non-invasive parameter of portal hypertension that distinguishes patients with clinically significant portal hypertension. It is a strong prognostic factor for survival.

Keywords: Cirrhosis; Complications of cirrhosis; Hepatic venous pressure gradient; Osteopontin; Portal hypertension; Prognosis; Survival prediction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Case-Control Studies
  • Disease Progression
  • Female
  • Humans
  • Hypertension, Portal / blood*
  • Hypertension, Portal / diagnosis
  • Hypertension, Portal / mortality
  • Hypertension, Portal / physiopathology
  • Kaplan-Meier Estimate
  • Linear Models
  • Liver Cirrhosis / blood*
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / mortality
  • Liver Cirrhosis / physiopathology
  • Logistic Models
  • Male
  • Middle Aged
  • Odds Ratio
  • Osteopontin / blood*
  • Portal Pressure*
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Up-Regulation

Substances

  • Biomarkers
  • SPP1 protein, human
  • Osteopontin

Associated data

  • EudraCT/2011-001132-30